|
|
|
Volumn 19, Issue 109, 2010, Pages 219-222
|
|
Chemotherapy of metastatic colorectal cancer: Fluorouracil (+ folinic acid), oxaliplatin, irinotecan, combinations depending on the situation
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
CAPECITABINE;
CETUXIMAB;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
OXALIPLATIN;
PANITUMUMAB;
PEMETREXED;
TEGAFUR;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLORECTAL CANCER;
DRUG EFFICACY;
HUMAN;
LIFE EXPECTANCY;
METASTASIS;
MONOTHERAPY;
NEUROTOXICITY;
REVIEW;
TREATMENT FAILURE;
UNSPECIFIED SIDE EFFECT;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
COLORECTAL NEOPLASMS;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
NEOPLASM METASTASIS;
ORGANOPLATINUM COMPOUNDS;
|
|
EID: 78650233991
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (11)
|
|
References (0)
|